New drug could boost stroke recovery after clot removal
NCT ID NCT07552610
First seen Apr 28, 2026 · Last updated Apr 28, 2026
Summary
This study tests whether adding the drug sivelestat sodium to standard clot-removal treatment helps people recover better after a stroke caused by a large blood vessel blockage. The drug aims to reduce brain inflammation that can limit recovery even after the clot is removed. About 868 adults aged 18-80 will be randomly assigned to receive either the drug or a placebo, and their level of disability will be measured after 90 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Xuanwu Hospital, Capital Medical University.
Beijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.